Exodus Point Capital Management, LP Abb Vie Inc. Put Options Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $1.16 Million - $1.36 Million	7,500 Added 46.3%	23,700 $4.07 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $2.59 Million - $2.95 Million	16,200 New	16,200 $2.95 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $1.61 Million - $2.17 Million	20,000 New	20,000 $2.14 Million

3,785

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.